ReproCell

ReproCell P/B

P/B (Razmerje cene in knjižne vrednosti) od ReproCell (4978.T) na dan 31. okt. 2026 je 1,75. V prejšnjem letu je P/B (Razmerje cene in knjižne vrednosti) znašal 1,72 — sprememba za 1,56 % (višje).

P/B

1,75

YoY

1,56%

Zadnja posodobitev:

P/B (Razmerje cene in knjižne vrednosti) od ReproCell je 2026 1,75 . P/B (Razmerje cene in knjižne vrednosti) od ReproCell je bil 2025 1,72 . Pada za 1,56% višje v primerjavi s prejšnjim letom.

Zgodovina ReproCell P/B

  • 3 leta

  • 10 let

  • 25 let

  • Največ

P/B
Datum
P/B
1. jan. 2019
2,18 JPY
1. jan. 2020
2,55 JPY
1. jan. 2021
2,87 JPY
1. jan. 2022
2,13 JPY
1. jan. 2023
2,04 JPY
1. jan. 2024
1,86 JPY
1. jan. 2025
1,72 JPY
1. jan. 2026
1,75 JPY
Zgodovina ReproCell P/B
LETOP/BYoY
1,75+1,56%
1,72−7,49%
1,86−8,86%
2,04−4,28%
2,13−25,74%
2,87+12,37%
2,55+16,85%
2,18−11,62%
2,47+17,93%
2,10−1,37%
2,13−2,51%
2,18−26,67%
2,97—

Do teh podatkov prek Eulerpool API

100.000 zahtevkov/mes. brezplačno · brez kartice

Pridobite brezplačen API ključ

ReproCell Analiza delnic

Kaj dela ReproCell? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell je eno najbolj priljubljenih podjetij na Eulopoolu.

Pogosto zastavljena vprašanja o delnici ReproCell

P/B (Razmerje cene in knjižne vrednosti) podjetja ReproCell znaša 1,75 v letu 2026.

P/B (Razmerje cene in knjižne vrednosti) od ReproCell se je spremenil z 1,72 na 1,75, kar predstavlja spremembo za 1,56 %. Vrednost je višje kot v prejšnjem letu.

Na Eulopoolu najdete celovit zgodovinski razvoj P/B (Razmerje cene in knjižne vrednosti) ReproCell od leta 2006 – z letnimi vrednostmi, grafi in podrobno analizo.

Razmerje cene in knjižne vrednosti primerja tržno ceno podjetja z njegovo knjižno vrednostjo. Nizko razmerje P/B lahko kaže na podcenjeno delnico, medtem ko visoko razmerje kaže na precenjevanje ali pričakovanja močne rasti.

P/B = Cena delnice / Knjižna vrednost na delnico

Za evalvacijo P/B (Razmerje cene in knjižne vrednosti)s je ključno primerjati s konkurenti v isti industriji in sektorju. Na Euloolu lahko najdete neposredne primerjave P/B (Razmerje cene in knjižne vrednosti) z drugimi podjetji.

Dobra vrednost za se razlikuje glede na industrijo in fazo razvoja podjetja. Na Euloolu lahko primerjate P/B (Razmerje cene in knjižne vrednosti)s ReproCell s podobnimi podjetji v sektorju in povprečjem industrije, da ocenite privlačnost.

Do teh podatkov prek Eulerpool API

100.000 zahtevkov/mes. brezplačno · brez kartice

Pridobite brezplačen API ključ

Vrednotenje — ReproCell

KGVKUVEV/EBITP/BP/CFP/FCFPEGEV/PrihodkiEV/EBITDAEV/FCFDonosnost čistega dohodkaFCF donosnostTržna kapitalizacijaVrednost podjetjaForward KGVCena/opredmeteni knjižni kapitalDonos lastnikaDonos odkupa delnicPEG prilagojen dividendamEV/OCF

Vse ključne metrike — ReproCell